Improved sensitive high performance liquid chromatography assay for glucosamine in human and rat biological samples with fluorescence detection

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 2, 2010, Pages 128-135

  Ibrahim, Alyaa ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

9 FLUORENYLMETHYL CHLOROFORMATE; ACETONITRILE; AMANTADINE; BORIC ACID; GLUCOSAMINE; MANNOSAMINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; FLOW RATE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; RAT; SEPARATION TECHNIQUE; URINE LEVEL; VALIDATION PROCESS;

EID: 78650342407     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3t01s     Document Type: Article

References (25)

1. Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1-148.
2. Kim MM, Mendis E, Rajapakse N, Kim SK. Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect. Bioorg Med Chem Lett. 2007;17:1938-42.
3. Duan W, Paka L, Pillarisetti S. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis. Cardiovasc Diabetol. 2005;4:16.
4. Yang S, Zou LY, Bounelis P, Chaudry I, Chatham JC, Marchase RB. Glucosamine administration during resuscitation improves organ function after trauma hemorrhage. Shock. 2006;25:600-7.
5. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007;56:2267-77.
6. Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol. 2002; 29:2407-9.
7. Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung. 1986;36:729-35.
8. Liang Z, Leslie J, Adebowale A, Ashraf M, Eddington ND. Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms and plasma using pre-column derivatization with ultraviolet HPLC. J Pharm Biomed Anal. 1999;20:807-14.
9. Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F. High performance liquid chromatographic determination of glucosamine in rat plasma. J Pharm Pharm Sci. 2002;5:176-80.
10. Beaudry F, Vachon P. Determination of glucosamine in horse plasma by liquid chromatography tandem mass spectrometry. Biomed Chromatogr. 2008;22:1-4.
11. Zhong S, Zhong D, Chen X. Improved and simplified liquid chromatography/ electrospray ionization mass spectrometry method for the analysis of underivatized glucosamine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;854:291-8.
12. Roda A, Sabatini L, Barbieri A, et al. Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;844:119-26.
13. Cheng X, Liao YH, Ge H, et al. TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol. 2005;25:246-53.
14. Yu Y, Cai L, Zuo M, Duan G. Precolumn derivatization liquid chromatography with mass spectrometry assay for the determination of glucosamine in small volume human plasma. Ann Chim. 2005;95:709-13.
15. Huang TM, Cai L, Yang B, Zhou MX, Shen YF, Duan GL. Liquid chromatography with electrospray ionization mass spectrometry method for the assay of glucosamine sulfate in human plasma: validation and application to a pharmacokinetic study. Biomed Chromatogr. 2006;20:251-6.
16. Zhang LJ, Huang TM, Fang XL, et al. Determination of glucosamine sulfate in human plasma by precolumn derivatization using high performance liquid chromatography with fluorescence detection: its application to a ioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;842:8-12.
17. Huang TM, Deng CH, Chen NZ, Liu Z, Duan GL. High performance liquid chromatography for the determination of glucosamine sulfate in human plasma after derivatization with 9-fluorenylmethyl chloroformate. J Sep Sci. 2006; 29 (15):2296-302.
18. Einarsson S, Josefsson B, Lagerkvist S. Determination of amino acids with 9-fluorenylmethyl chloroformate and reversed-phase highperformance liquid chromatography. Journal of Chromatography A. 1983;282:609-618.
19. Golaz O, Wilkins MR, Sanchez JC, Appel RD, Hochstrasser DF, Williams KL. Identification of proteins by their amino acid composition: an evaluation of the method. Electrophoresis. 1996; 17:573-9.
20. Desaire H, Leary JA. Multicomponent quantification of diastereomeric hexosamine monosaccharides using ion trap tandem mass spectrometry. Anal Chem. 1999;71:4142-7.
21. Gustavsson B, Betner I. Fully automated amino acid analysis for protein and peptide hydrolysates by precolumn derivatization with 9-fluorenylmethyl chloroformate and 1-aminoadamantane. J. Chromatogr. 1990; 507:67-77.
22. Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J Pharm Pharm Sci. 2002;5:181-4.
23. Jackson CG, Plaas AH, Sandy JD, et al. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. 2009; 18: 297-302.
24. Biggee BA, Blinn CM, McAlindon TE, Nuite M, Silbert JE. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis. 2006;65:222-6.
25. Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage. 2005;13:1041-9.